Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nava Zisapel

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
BMC Medicine|August 18, 2010
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safetyAlan G Wade, Ian Ford, Gordon Crawford, et al.
Current Medical Research and Opinion|November 25, 2010
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term responseAlan G Wade, Gordon Crawford, Ian Ford, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
CD44 Splice Variants as Potential Players in Alzheimer's Disease PathologyElhanan Pinner, Yaron Gruper, Micha Ben Zimra, et al.
Current Medical Research and Opinion|September 19, 2007
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomesAlan G Wade, Ian Ford, Gordon Crawford, et al.
Clinical Interventions in Aging|June 28, 2014
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trialAlan G Wade, Mildred Farmer, Gil Harari, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 27, 2020
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum DisorderBeth A Malow, Robert L Findling, Carmen M Schroder, et al.
The American Journal of Medicine|September 27, 2006
Melatonin reduces night blood pressure in patients with nocturnal hypertensionEhud Grossman, Moshe Laudon, Ridvan Yalcin, et al.
Progress in Neurobiology|June 24, 2008
Physiological effects of melatonin: role of melatonin receptors and signal transduction pathwaysSeithikurippu R Pandi-Perumal, Ilya Trakht, Venkataramanujan Srinivasan, et al.
Journal of Child and Adolescent Psychopharmacology|August 23, 2018
Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum DisorderAthanasios Maras, Carmen M Schroder, Beth A Malow, et al.
Journal of Autism and Developmental Disorders|May 13, 2019
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of LifeCarmen M Schroder, Beth A Malow, Athanasios Maras, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
BMC Medicine|August 18, 2010
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safetyAlan G Wade, Ian Ford, Gordon Crawford, et al.
Current Medical Research and Opinion|November 25, 2010
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term responseAlan G Wade, Gordon Crawford, Ian Ford, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
CD44 Splice Variants as Potential Players in Alzheimer's Disease PathologyElhanan Pinner, Yaron Gruper, Micha Ben Zimra, et al.
Current Medical Research and Opinion|September 19, 2007
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomesAlan G Wade, Ian Ford, Gordon Crawford, et al.
Clinical Interventions in Aging|June 28, 2014
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trialAlan G Wade, Mildred Farmer, Gil Harari, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 27, 2020
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum DisorderBeth A Malow, Robert L Findling, Carmen M Schroder, et al.
The American Journal of Medicine|September 27, 2006
Melatonin reduces night blood pressure in patients with nocturnal hypertensionEhud Grossman, Moshe Laudon, Ridvan Yalcin, et al.
Progress in Neurobiology|June 24, 2008
Physiological effects of melatonin: role of melatonin receptors and signal transduction pathwaysSeithikurippu R Pandi-Perumal, Ilya Trakht, Venkataramanujan Srinivasan, et al.
Journal of Child and Adolescent Psychopharmacology|August 23, 2018
Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum DisorderAthanasios Maras, Carmen M Schroder, Beth A Malow, et al.
Journal of Autism and Developmental Disorders|May 13, 2019
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of LifeCarmen M Schroder, Beth A Malow, Athanasios Maras, et al.
Pageof 5